NCT04054284

Brief Summary

Nearly 25% of the world's population relies on traditional medicinal systems but for professionals their effectiveness and even more safety are the main concern. Therefore, the aim of this preliminary study is to assess safety and effectiveness of herbal tea mixture on the control of glycaemia in Type 2 diabetics.The mixture consists of nine plants which have well-documented traditional use for the control of glycaemia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P50-P75 for not_applicable type-2-diabetes

Timeline
Completed

Started Jul 2019

Shorter than P25 for not_applicable type-2-diabetes

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2019

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

July 29, 2019

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 13, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2020

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 12, 2020

Completed
Last Updated

February 13, 2020

Status Verified

February 1, 2020

Enrollment Period

7 months

First QC Date

July 29, 2019

Last Update Submit

February 12, 2020

Conditions

Keywords

Type 2 DiabetesHerbal MedicineSafetyGlycaemia ControlAlternative Therapy

Outcome Measures

Primary Outcomes (1)

  • Number of patients with adverse event

    Adverse event (e.g. hypoglycaemia) reporting through direct contact researcher-patient.

    Starting from baseline, once per week until study completion at week 12.

Secondary Outcomes (2)

  • Glycated Hemoglobin

    At enrollment (baseline) and at the end of the intervention (at 12 weeks).

  • Fasting Glucose

    At enrollment (baseline) and at the end of the intervention (at 12 weeks).

Other Outcomes (10)

  • Creatinine

    At enrollment (baseline) and at the end of the intervention (at 12 weeks).

  • Urea

    At enrollment (baseline) and at the end of the intervention (at 12 weeks).

  • Total Proteins

    At enrollment (baseline) and at the end of the intervention (at 12 weeks).

  • +7 more other outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Herbal Tea Mixture is consisted of: Vaccinium myrtillus L. folium, Morus nigra L. folium, Phaseolus vulgaris L. pericarpium, Viscum album L. herba, Urtica dioica L. radix, Gentiana lutea L. radix, Taraxacum officinale W. radix, Cichorium intybus L. herba, Teucrium chamaedrys L. herba, Stevia rebaudiana folium.

Dietary Supplement: Antidiabetic Herbal Tea

Control

ACTIVE COMPARATOR

Herbal Tea Mixture without antidiabetic properties is consisted of: Achillea millefolium L. herba, Teucrium montanum L. herba, Glechoma hederacea L. herba, Eupatorium cannabinum L. herba, Humulus lupulus L. lupulin, Artemisia absinthium L. herba, Salvia officinalis L.

Dietary Supplement: Herbal Tea

Interventions

Antidiabetic Herbal TeaDIETARY_SUPPLEMENT

Patients will be instructed to take 250 mL of freshly prepared tea (1 tea spoon or 3 g of tea, pour over 250 mL of boiling water and leave aside for 15 min) 2 times per day during 12 weeks. The first tea needs to be taken in the morning prior any meal. The second can be taken at any time during the day but with at least 4 hour difference from the first cup.

Also known as: Experimental-Intervention
Intervention
Herbal TeaDIETARY_SUPPLEMENT

Patients will be instructed to take 250 mL of freshly prepared tea (1 tea spoon or 3 g of tea, pour over 250 mL of boiling water and leave aside for 15 min) 2 times per day during 12 weeks. The first tea needs to be taken in the morning prior any meal. The second can be taken at any time during the day but with at least 4 hour difference from the first cup.

Also known as: Active Comparator-Control
Control

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • signed informed consent
  • Croatian-speaking
  • stable therapy for at least 3 months prior enrollment
  • not taking any dietary supplements, especially herbal-based
  • not taking any other herbal medicine (as a tea or a supplement)
  • stable dietary and lifestyle patterns for at least 3 months prior enrollment

You may not qualify if:

  • type 1 diabetes
  • severe somatic disorder (oncological disease, hepatic, renal or autoimmune disease)
  • pregnancy
  • inability to fill in questionnaires in Croatian
  • cognitive impairment
  • psychiatric disorder
  • undergoing current treatment for a major medical illness such as malignancy, autoimmune or immune deficiency disorder
  • clotting disorders
  • having nutritional deficiency (e.g. iron deficiency)
  • current or history of eating disorder (anorexia, bulimia or EDNOS)
  • current use of weight loss interventions (drugs; exercise interventions)
  • regular use of dietary supplements, especially herbal-based
  • regular use of herbal medicine (as a tea or a supplement)
  • significant changes in diet or lifestyle patterns (e.g. increased physical activity) in the last 3 months prior the enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Department of Food and Nutrition Research, Faculty of Food Technology

Osijek, 31000, Croatia

Location

Health Centre Osijek

Osijek, 31000, Croatia

Location

University Hospital Centre

Osijek, 31000, Croatia

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Teas, Herbal

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Plant PreparationsBiological ProductsComplex MixturesBeveragesDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Ines Banjari, PhD

    Department of Food and Nutrition Research, Faculty of Food Technology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Prof. Dr.

Study Record Dates

First Submitted

July 29, 2019

First Posted

August 13, 2019

Study Start

July 1, 2019

Primary Completion

February 10, 2020

Study Completion

February 12, 2020

Last Updated

February 13, 2020

Record last verified: 2020-02

Locations